{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T04:03:31Z","timestamp":1769918611669,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Forensic Sci Med Pathol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s12024-020-00334-0","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T09:09:23Z","timestamp":1605258563000},"page":"3-9","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Emergence of Cumyl-PEGACLONE-related fatalities in the Northern Territory of Australia"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8437-6683","authenticated-orcid":false,"given":"Marianne","family":"Tiemensma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John David","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Karch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"key":"334_CR1","unstructured":"Australian Bureau of Statistics. 2016. https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/mediareleasesbyCatalogue\/C73D7CC81CA1FD2FCA258148000A4067?OpenDocument. Accessed 18 May 2020."},{"key":"334_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/jat\/bky099","volume":"43","author":"C Nash","year":"2018","unstructured":"Nash C, Butzbach D, Stockham P, et al. A fatality involving Furanylfentanyl and MMMP, with presumptive identification of three MMMP metabolites in urine. J Anal Toxicol. 2018;43:291\u20138.","journal-title":"J Anal Toxicol"},{"key":"334_CR3","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/dta.2685","volume":"11","author":"C Nash","year":"2019","unstructured":"Nash C, Glowacki L, Gerostamoulos D, et al. Identification of a thermal degradation product of CUMYL-PEGACLONE and its detection in biological samples. Drug Test Anal. 2019;11:1480\u20135.","journal-title":"Drug Test Anal"},{"key":"334_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/dta.2225","volume":"10","author":"S Elliott","year":"2018","unstructured":"Elliott S, Sedefov R, Evans-Brown M. Assessing the toxicological significance of new psychoactive substances in fatalities. Drug Test Anal. 2018;10:120\u20136.","journal-title":"Drug Test Anal"},{"key":"334_CR5","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/S0025-6196(12)64946-5","volume":"63","author":"D Kitzman","year":"1988","unstructured":"Kitzman D, Scholz DG, Hagen PT, et al. Age-related changes in normal human hearts during the first 10 decades of life. Part II (Maturity). A quantitative anatomic study of 765 specimens from subjects 20 to 99 years old. Mayo Clin Proc. 1988;63:1237\u201346.","journal-title":"Mayo Clin Proc."},{"key":"334_CR6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s11419-019-00514-w","volume":"38","author":"A Giorgetti","year":"2019","unstructured":"Giorgetti A, Mogler L, Halter SD, et al. Four cases of death involving the novel synthetic cannabinoid 5F-Cumyl-PEGACLONE. Forensic Toxicol. 2019;38:314\u201326.","journal-title":"Forensic Toxicol"},{"key":"334_CR7","unstructured":"Alcohol, tobacco & other drugs in Australia, New (and emerging) psychoactive substances - Australian Institute Of Health And Welfare. 2020. https:\/\/www.aihw.gov.au\/reports\/phe\/221\/alcohol-tobacco-other-drugs-australia\/contents\/drug-types\/new-and-emerging-psychoactive-substances. Accessed 25 May 2020."},{"key":"334_CR8","unstructured":"Misuse of Drugs (Act Amendment) Regulations 2020 (No.9) (NT) (Austl.) https:\/\/legislation.nt.gov.au\/en\/Subordinate-Legislation\/Misuse-of-Drugs-Act-Amendment-Regulations-2020-SL-9. Accessed 28 May 2020."},{"key":"334_CR9","volume-title":"Northern Territory drug trends 2018: Key findings from the Illicit Drug Reporting System (IDRS) Interviews","author":"C Moon","year":"2019","unstructured":"Moon C. Northern Territory drug trends 2018: Key findings from the Illicit Drug Reporting System (IDRS) Interviews. Sydney: National Drug and Alcohol Research Centre, UNSW Australia; 2019."},{"key":"334_CR10","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1080\/15563650.2019.1647344","volume":"58","author":"S Darke","year":"2020","unstructured":"Darke S, Duflou J, Farrel M, et al. Characteristics and circumstances of synthetic cannabinoid-related death. Clin Toxicol. 2020;58:368\u201374.","journal-title":"Clin Toxicol"},{"key":"334_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/dta.2545","volume":"11","author":"S Halter","year":"2018","unstructured":"Halter S, Angerer V, Rohrich J, et al. Cumyl-PEGACLONE: A comparatively safe new synthetic cannabinoid receptor agonis entering the NPS market. Drug Test Anal. 2018;11:347\u20139.","journal-title":"Drug Test Anal"},{"key":"334_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.forsciint.2019.02.021","volume":"298","author":"M Kraemer","year":"2019","unstructured":"Kraemer M, Boehmer A, Madea B, et al. Death cases involving certain new psychoactive substances: a review of the literature. Forensic Sci Int. 2019;298:186\u2013267.","journal-title":"Forensic Sci Int"},{"key":"334_CR13","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/dta.2870","volume":"12","author":"L Janssens","year":"2020","unstructured":"Janssens L, Cannaert A, Conolly MJ, et al. In vitro activity profiling of Cumyl-PEGACLONE variants at the CB1 receptor: Fluorination versus isomer exploration. Drug Test Anal. 2020;12:1336\u201343.","journal-title":"Drug Test Anal"},{"key":"334_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.23907\/2014.028","volume":"4","author":"KS Cunningham","year":"2014","unstructured":"Cunningham KS. Alcohol and heart disease in the forensic setting. Acad Forensic Pathol. 2014;4:172\u20139.","journal-title":"Acad Forensic Pathol"},{"key":"334_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrcardio.2017.130","volume":"15","author":"P Pacher","year":"2018","unstructured":"Pacher P, Steffens S, Hasko G, et al. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Nat Rev Cardiol. 2018;15:151\u201366.","journal-title":"Nat Rev Cardiol"}],"container-title":["Forensic Science, Medicine and Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-020-00334-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12024-020-00334-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-020-00334-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T03:06:17Z","timestamp":1613703977000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12024-020-00334-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["334"],"URL":"https:\/\/doi.org\/10.1007\/s12024-020-00334-0","relation":{},"ISSN":["1547-769X","1556-2891"],"issn-type":[{"value":"1547-769X","type":"print"},{"value":"1556-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"assertion":[{"value":"19 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ethics approval was granted by the Human Research Ethics Committee of the Northern Territory Department of Health and Menzies School of Health Research and permission for this research was granted by the NT Coroner\u2019s Office.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The anonymized data used in the study was considered to be low risk, with no impact on the deceased study subjects or their relatives, and therefore a waiver of informed consent to the use of data applied.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and consent for publication"}}]}}